SGRY
Surgery Partners Inc
13.70$
+3.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +284.9% | +48.2% | -3.4% | +19.6% | -10.4% | +90.7% | -64.7% | +82.3% | +85.0% | +2.1% | -8.6% | |
| – | +129.4% | +14.5% | +31.3% | +29.9% | +13.4% | +23.9% | +4.2% | +16.2% | +2.9% | +29.2% | +15.3% | |
| – | +696.4% | -73.1% | +177.1% | +66.9% | +9.2% | +29.4% | +31.8% | +5.7% | -3.8% | +88.1% | -55.6% | |
| – | -2.1% | +37.5% | -48.6% | +77.6% | -64.7% | -34.5% | +40.7% | +28.9% | – | – | – | |
| – | – | – | – | -61.0% | -307.5% | – | – | – | – | – | – | |
| – | +254.4% | +17.0% | -24.3% | +34.5% | +84.9% | -41.7% | +34.3% | +39.9% | +10.2% | +1.8% | -12.9% | |
| – | -50.2% | +37.0% | +324.1% | -83.6% | -33.9% | +3.8% | +275.2% | -7.2% | -26.7% | +116.5% | -49.5% | |
| – | -98.6% | +6,425.4% | -98.5% | +492.7% | +1,453.8% | -9.6% | -95.3% | +2,778.4% | -100.0% | – | – | |
| – | – | -100.0% | – | +0.0% | +60.0% | +756.3% | +752.2% | – | – | – | – | |
| – | -127.5% | – | +253.6% | -80.4% | -94.1% | +2,741.7% | -127.1% | +1,060.7% | – | +2,209.7% | -63.9% | |
| – | -89.3% | +113.6% | +977.1% | -100.8% | +2,057.1% | – | +374.2% | -86.7% | -468.6% | – | -121.9% | |
| – | -127.4% | – | +0.0% | -20.2% | -1,075.1% | – | -68.2% | -249.2% | – | – | -140.2% | |
| – | +307.9% | +68.7% | +6.1% | +14.7% | -46.7% | +264.9% | -85.5% | +165.1% | +162.1% | +2.3% | -6.7% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.